Supply chain, logistics

Acquisition of Novartis’ Swiss site gives Lonza its first sterile drug product facility

01-Jul-2019 By Maggie Lynch

Lonza adds its first sterile drug product fill-finish facility to its network after acquiring Novartis’ Swiss plant, building on its parenteral drug product development and testing capabilities for clinical trial supply.

Automatic quality control application to potentially reduce timelines by a third

01-Jul-2019 By Maggie Lynch

MMS Holdings launched its cloud-based quality control application, Automatiqc, to meet quality control needs rapidly through its customizable software, according to the CRO.

Parexel introduces FSP outsourcing model at DIA

27-Jun-2019 By Maggie Lynch

Parexel launched a delivery model for its FSP services at DIA 2019 Global Annual Meeting in San Diego as the company aims to tailor solutions for biopharma customers.

Signant Health CEO talks investments and growth opportunities a year after CRF, Bracket merger

24-Jun-2019 By Melissa Fassbender

CRF Bracket – newly-rebranded as Signant Health – is looking to build momentum around eConsent, rethink the patient’s connection to the supply chain, and build out a stronger analytics platform, says CEO.

Be The Match and TrakCel partner on integrated services for cell therapy developers

24-Jun-2019 By Vassia Barba

Be The Match BioTherapies and TrakCel form a strategic partnership to integrate their offering for companies developing cell and gene therapies.

AirBridgeCargo expands partnership with SkyCell for temperature-controlled containers

18-Jun-2019 By Melissa Fassbender

The Russian all-cargo airline AirBridgeCargo Airlines (ABC) has expanded its SkyCell partnership through which it will lease SkyCell’s containers as sales of temperature-sensitive products boom.

Almac meets evolving trial design with ‘on demand’ supply solution

17-Jun-2019 By Maggie Lynch

In an aim to optimize the performance of changing clinical trials, Almac Clinical Services launched a supply chain solution – Almac Adapt – to provide sponsors with an adaptive supply strategy.

Medidata acquired by French software firm Dassault Systèmes for $5.8bn

12-Jun-2019 By Melissa Fassbender

Dassault Systèmes is set to acquire Medidata in an all-cash transaction valued at $5.8bn – a deal which will combine the power of modeling and simulation with data science to “catalyze the next generation of patient-inclusive therapeutics,” says CEO.

PCI Pharma adds another San Diego facility as storage needs grow

10-Jun-2019 By Maggie Lynch

PCI Pharma Services adds a third facility in San Diego as it continues to grow its west coast clinical operations.

STA Pharma completes clinical supply of PhoenixMD’s breast cancer treatment

10-Jun-2019 By Maggie Lynch

Clinical trial supply for the first targeted treatment of triple-negative breast cancer completed through PhoenixMD and STA Pharmaceutical agreement.

PE firm Ampersand acquires German CDMO Vibalogics

03-Jun-2019 By Maggie Lynch

The private equity firm Ampersand Capital has acquired Vibalogics with plans to increase development and manufacturing capabilities for complex viral products.

Vetter goes green and supplies German sites with neutral energy

29-May-2019 By Maggie Lynch

Vetter’s German sites will be supplied with only CO2 neutral energy from renewable energy sources as the company continues to work towards greater sustainability.

Rexgenero extends European reach with expanded manufacturing

29-May-2019 By Maggie Lynch

Partnership with German Red Cross will see Rexgenero’s lead drug candidate reaching broader patient base in clinical trials.

SGS’ Glasgow biosafety facility doubles in size

28-May-2019 By Maggie Lynch

SGS’ completed the ₤8.7m expansion of its large molecule testing facility in Glasgow and made room to increase its existing biosafety service and PCR platform capabilities.

Advarra aims to accelerate pediatric trials in an agreement

23-May-2019 By Maggie Lynch

Advarra will provide IRB services to the Institute for Advanced Clinical Trials for Children’s pediatric clinical trial site network.